Capricor Therapeutics Stock Math Operators Price Series Summation
| CAPR Stock | USD 30.50 -2.92 -8.74% |
| Symbols |
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Capricor Therapeutics Price Series Summation is a cross summation of Capricor Therapeutics price series and its benchmark/peer.
Capricor Therapeutics Technical Analysis Modules
Most technical analysis of Capricor Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Capricor from various momentum indicators to cycle indicators. When you analyze Capricor charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. The company was founded in 2005 and is headquartered in San Diego, California. Capricor Therap operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people. A high-level view of Capricor Therapeutics emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/E of 42.39, P/B of 21.68. Capricor Therapeutics has a market cap of 1.66 B, P/E of 42.39, ROE of -107.79%.
Methodology
Unless otherwise specified, financial data for Capricor Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Capricor (USA Stocks:CAPR) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Capricor Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Capricor Therapeutics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardLearn to be your own money manager
Tracking Capricor Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Capricor Therapeutics pair trading
Pair trading with Capricor Therapeutics can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Capricor Therapeutics Pair Trading
Capricor Therapeutics Pair Trading Analysis
Understanding the correlation structure around Capricor Therapeutics helps portfolio managers make better tax-loss harvesting decisions. A highly correlated substitute for Capricor Therapeutics ensures that the portfolio's expected return and risk profile remain largely intact through the wash-sale.
Investors use the correlation of Capricor Therapeutics to identify pairs-trading opportunities. When two historically correlated assets diverge temporarily, a long/short position combining Capricor Therapeutics with the diverging counterpart can generate returns with minimal net market exposure.
Correlation analysis and pair evaluation for Capricor Therapeutics can support hedging context. The context can be applied within sectors, industries, or broader universes.Additional Tools for Capricor Stock Analysis
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance |